Financings Of The Fortnight: Top-Ups The Latest Trend In Biopharmaceutical Deals
This article was originally published in The Pink Sheet Daily
Executive Summary
China Nuokang Bio-Pharmaceutical, Dendreon, Afferent Pharmaceuticals, and Molecular Partners end the year with new funds.